SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001114220-17-000028
Filing Date
2017-09-13
Accepted
2017-09-13 20:57:34
Documents
1
Period of Report
2017-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150535063941262.html 4  
1 FORM 4 wf-form4_150535063941262.xml 4 3936
  Complete submission text file 0001114220-17-000028.txt   5305
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Enyedy Mark J (Reporting) CIK: 0001586965 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 171084392